​

Labcorp (LH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LH Stock Forecast

Labcorp (LH) stock forecast, based on 35 Wall Street analysts, predicts a 12-month average price target of $290.00, with a high of $305.00 and a low of $275.00. This represents a 10.74% increase from the last price of $261.88.

$150 $190 $230 $270 $310 $350 High: $305 Avg: $290 Low: $275 Last Closed Price: $261.88

LH Stock Rating

Labcorp stock's rating consensus is Buy, based on 35 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 27 Buy (77.14%), 8 Hold (22.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 35 0 8 27 Strong Sell Sell Hold Buy Strong Buy

LH Price Target Upside V Benchmarks

TypeNameUpside
StockLabcorp10.74%
SectorHealthcare Stocks 18.80%

Price Target Trends

1M3M12M
# Anlaysts128
Avg Price Target$305.00$290.00$267.75
Last Closing Price$261.88$261.88$261.88
Upside/Downside16.47%10.74%2.24%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 253134--20
Jun, 253134--20
May, 254133--20
Apr, 252125--19
Mar, 252116--19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 25, 2025Kevin CaliendoUBS$305.00$264.9615.11%16.47%
Jun 25, 2025Barclays$275.00$258.706.30%5.01%
Feb 03, 2025Luke SergottBarclays$271.00$247.869.34%3.48%
Sep 24, 2024Elizabeth AndersonEvercore ISI$240.00$224.726.80%-8.35%
Sep 23, 2024Brian TanquilutJefferies$265.00$222.2219.25%1.19%
Aug 05, 2024Michael RyskinBank of America Securities$260.00$236.0010.17%-0.72%
Aug 02, 2024Stephanie DavisBarclays$249.00$235.675.66%-4.92%
Aug 02, 2024Eric ColdwellRobert W. Baird$277.00$235.6717.54%5.77%
Mar 25, 2024David ToungArgus Research$250.00$212.5017.65%-4.54%
Jan 06, 2023Morgan Stanley$303.00$241.4225.51%15.70%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 25, 2025UBSBuyBuyhold
Jul 10, 2025HSBCBuyHolddowngrade
Jun 25, 2025BarclaysCautiousCautioushold
May 06, 2025Piper SandlerNeutralNeutralhold
Mar 04, 2025CitigroupNeutralBuyupgrade
Jan 07, 2025Evercore ISIOutperformupgrade
Oct 30, 2024HSBCBuyupgrade
Oct 01, 2024Piper SandlerNeutralinitialise
Sep 23, 2024JefferiesBuyBuyhold
Aug 05, 2024Bank of America SecuritiesBuyBuyhold

Financial Forecast

EPS Forecast

$0 $5 $10 $15 $20 $25 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$15.99$24.58$14.04$4.80------
Avg Forecast$18.41$23.84$17.07$13.54$14.52$16.04$17.65$19.56$21.53$21.67
High Forecast$18.41$23.84$17.07$13.64$14.56$16.28$18.43$21.27$21.84$21.98
Low Forecast$18.41$23.84$17.07$13.48$14.45$15.82$16.45$17.16$21.22$21.36
Surprise %-13.15%3.10%-17.75%-64.55%------

Revenue Forecast

$12B $13B $14B $15B $16B $17B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$13.98B$16.12B$14.88B$12.16B------
Avg Forecast$13.54B$16.01B$14.94B$12.15B$12.99B$13.90B$14.58B$15.40B$16.37B$14.78B
High Forecast$13.54B$16.01B$14.94B$12.16B$13.01B$14.05B$14.86B$15.48B$16.55B$14.94B
Low Forecast$13.54B$16.01B$14.94B$12.14B$12.98B$13.82B$14.25B$15.32B$16.19B$14.61B
Surprise %3.24%0.70%-0.44%0.13%------

Net Income Forecast

$0 $500M $1B $2B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$1.56B$2.38B$1.28B$418.00M------
Avg Forecast$873.20M$1.89B$1.74B$379.20M$1.22B$1.35B$1.47B$1.62B$1.81B$1.82B
High Forecast$1.15B$2.26B$2.08B$455.04M$1.23B$1.37B$1.55B$1.79B$1.84B$1.85B
Low Forecast$599.01M$1.51B$1.39B$303.36M$1.22B$1.33B$1.39B$1.44B$1.79B$1.80B
Surprise %78.21%25.95%-26.30%10.23%------

LH Forecast FAQ

Is Labcorp stock a buy?

Labcorp stock has a consensus rating of Buy, based on 35 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 27 Buy, 8 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Labcorp is a favorable investment for most analysts.

What is Labcorp's price target?

Labcorp's price target, set by 35 Wall Street analysts, averages $290 over the next 12 months. The price target range spans from $275 at the low end to $305 at the high end, suggesting a potential 10.74% change from the previous closing price of $261.88.

How does Labcorp stock forecast compare to its benchmarks?

Labcorp's stock forecast shows a 10.74% upside, underperforming the average forecast for the healthcare stocks sector (18.80%).

What is the breakdown of analyst ratings for Labcorp over the past three months?

  • July 2025: 15.00% Strong Buy, 65.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 15.00% Strong Buy, 65.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 20.00% Strong Buy, 65.00% Buy, 15.00% Hold, 0% Sell, 0% Strong Sell.

What is Labcorp’s EPS forecast?

Labcorp's average annual EPS forecast for its fiscal year ending in December 2024 is $14.52, marking a 202.50% increase from the reported $4.8 in 2023. Estimates for the following years are $16.04 in 2025, $17.65 in 2026, $19.56 in 2027, $21.53 in 2028, and $21.67 in 2029.

What is Labcorp’s revenue forecast?

Labcorp's average annual revenue forecast for its fiscal year ending in December 2024 is $12.99B, reflecting a 6.79% increase from the reported $12.16B in 2023. The forecast for 2025 is $13.9B, followed by $14.58B for 2026, $15.4B for 2027, $16.37B for 2028, and $14.78B for 2029.

What is Labcorp’s net income forecast?

Labcorp's net income forecast for the fiscal year ending in December 2024 stands at $1.22B, representing an 192.21% increase from the reported $418M in 2023. Projections indicate $1.35B in 2025, $1.47B in 2026, $1.62B in 2027, $1.81B in 2028, and $1.82B in 2029.